Urologix, Inc. (ULGX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2013 | -6.34 Million USD | 84.65% |
| 2012 | -3.04 Million USD | 9.36% |
| 2011 | -3.46 Million USD | -9.14% |
| 2010 | -3.16 Million USD | -115.92% |
| 2009 | -1.46 Million USD | 58.08% |
| 2008 | -3.43 Million USD | 35.5% |
| 2007 | -15.2 Million USD | 18.85% |
| 2006 | -6.11 Million USD | -339.66% |
| 2005 | 2.78 Million USD | -44.36% |
| 2004 | 5.15 Million USD | 128.91% |
| 2003 | 2.69 Million USD | 136.83% |
| 2002 | -5.93 Million USD | -4610.32% |
| 2001 | -126 Thousand USD | 96.8% |
| 2000 | -3.93 Million USD | 44.31% |
| 1999 | -7.06 Million USD | 50.62% |
| 1998 | -14.3 Million USD | -31.19% |
| 1997 | -10.9 Million USD | 4.39% |
| 1996 | -11.4 Million USD | -44.3% |
| 1995 | -7.9 Million USD | -31.67% |
| 1994 | -6 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2014 Q2 | -18 Thousand USD | 83.18% |
| 2014 Q1 | -107 Thousand USD | 68.15% |
| 2014 Q3 | -42 Thousand USD | -133.33% |
| 2013 Q3 | -1.32 Million USD | -76.97% |
| 2013 Q4 | -336 Thousand USD | 74.58% |
| 2013 FY | - USD | 84.65% |
| 2013 Q1 | -1 Million USD | -61.32% |
| 2013 Q2 | -747 Thousand USD | 25.67% |
| 2012 Q1 | -908 Thousand USD | -0.22% |
| 2012 FY | - USD | 9.36% |
| 2012 Q2 | -877 Thousand USD | 3.41% |
| 2012 Q4 | -623 Thousand USD | 13.23% |
| 2012 Q3 | -718 Thousand USD | 18.13% |
| 2011 Q4 | -906 Thousand USD | -39.81% |
| 2011 Q2 | -714 Thousand USD | 39.7% |
| 2011 Q1 | -1.18 Million USD | 0.84% |
| 2011 FY | - USD | -9.14% |
| 2011 Q3 | -648 Thousand USD | 9.24% |
| 2010 FY | - USD | -115.92% |
| 2010 Q4 | -1.19 Million USD | -40.14% |
| 2010 Q3 | -852 Thousand USD | -48.43% |
| 2010 Q2 | -574 Thousand USD | -6.1% |
| 2010 Q1 | -541 Thousand USD | -4.04% |
| 2009 Q3 | -404 Thousand USD | -417.95% |
| 2009 FY | - USD | 58.08% |
| 2009 Q4 | -520 Thousand USD | -28.71% |
| 2009 Q2 | -78 Thousand USD | 83.15% |
| 2009 Q1 | -463 Thousand USD | 34.14% |
| 2008 Q2 | -817 Thousand USD | 18.22% |
| 2008 FY | - USD | 35.5% |
| 2008 Q4 | -703 Thousand USD | 27.67% |
| 2008 Q1 | -999 Thousand USD | 49.82% |
| 2008 Q3 | -972 Thousand USD | -18.97% |
| 2007 Q4 | -1.99 Million USD | -3.86% |
| 2007 Q3 | -1.91 Million USD | -45.45% |
| 2007 Q1 | -188 Thousand USD | 96.51% |
| 2007 Q2 | -1.31 Million USD | -601.06% |
| 2007 FY | - USD | 18.85% |
| 2006 FY | - USD | -339.66% |
| 2006 Q4 | -5.39 Million USD | -1348.92% |
| 2006 Q3 | -372 Thousand USD | -168.76% |
| 2006 Q2 | 541 Thousand USD | 483.69% |
| 2006 Q1 | -141 Thousand USD | -130.13% |
| 2005 Q2 | 811 Thousand USD | 37.46% |
| 2005 Q1 | 590 Thousand USD | -51.44% |
| 2005 FY | - USD | -44.36% |
| 2005 Q3 | 915 Thousand USD | 12.82% |
| 2005 Q4 | 468 Thousand USD | -48.85% |
| 2004 Q2 | 1.27 Million USD | -0.7% |
| 2004 Q1 | 1.28 Million USD | -1.99% |
| 2004 Q4 | 1.21 Million USD | -1.54% |
| 2004 FY | - USD | 128.91% |
| 2004 Q3 | 1.23 Million USD | -3.06% |
| 2003 FY | - USD | 136.83% |
| 2003 Q1 | -57 Thousand USD | 97.51% |
| 2003 Q2 | -184 Thousand USD | -222.81% |
| 2003 Q3 | 1.11 Million USD | 708.15% |
| 2003 Q4 | 1.3 Million USD | 16.89% |
| 2002 Q2 | -2.03 Million USD | -58.98% |
| 2002 FY | - USD | -4610.32% |
| 2002 Q4 | -2.29 Million USD | -43.13% |
| 2002 Q1 | -1.28 Million USD | -1433.33% |
| 2002 Q3 | -1.6 Million USD | 21.28% |
| 2001 Q2 | -123 Thousand USD | 70.57% |
| 2001 Q3 | 319 Thousand USD | 359.35% |
| 2001 Q4 | 96 Thousand USD | -69.91% |
| 2001 FY | - USD | 96.8% |
| 2001 Q1 | -418 Thousand USD | 74.85% |
| 2000 Q2 | -1.23 Million USD | 22.74% |
| 2000 Q4 | -1.66 Million USD | -1340.3% |
| 2000 FY | - USD | 44.31% |
| 2000 Q1 | -1.59 Million USD | 6.2% |
| 2000 Q3 | 134 Thousand USD | 110.89% |
| 1999 Q4 | -1.69 Million USD | -1.96% |
| 1999 Q3 | -1.66 Million USD | -4.04% |
| 1999 Q1 | -2.1 Million USD | 22.22% |
| 1999 FY | - USD | 50.62% |
| 1999 Q2 | -1.6 Million USD | 23.81% |
| 1998 Q2 | -3.5 Million USD | 48.53% |
| 1998 Q4 | -2.7 Million USD | 6.9% |
| 1998 Q3 | -2.9 Million USD | 17.14% |
| 1998 Q1 | -6.8 Million USD | -353.33% |
| 1998 FY | - USD | -31.19% |
| 1997 Q1 | -2.1 Million USD | 41.67% |
| 1997 Q3 | -4.6 Million USD | -84.0% |
| 1997 Q4 | -1.5 Million USD | 67.39% |
| 1997 FY | - USD | 4.39% |
| 1997 Q2 | -2.5 Million USD | -19.05% |
| 1996 Q3 | -2.5 Million USD | 0.0% |
| 1996 Q4 | -3.6 Million USD | -44.0% |
| 1996 FY | - USD | -44.3% |
| 1996 Q1 | -2.7 Million USD | 66.67% |
| 1996 Q2 | -2.5 Million USD | 7.41% |
| 1995 FY | - USD | -31.67% |
| 1995 Q3 | 100 Thousand USD | 0.0% |
| 1995 Q1 | 100 Thousand USD | 101.64% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q4 | -8.1 Million USD | -8200.0% |
| 1994 Q2 | 100 Thousand USD | 0.0% |
| 1994 Q4 | -6.1 Million USD | -6200.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q1 | 100 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -2212.881% |
| IR-Med Inc. | -4.89 Million USD | -29.681% |
| Polarean Imaging plc | -11.19 Million USD | 43.332% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 1491.045% |
| Avitar, Inc. | -1.66 Million USD | -280.381% |
| AVITA Medical, Inc. | -39.56 Million USD | 83.967% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -445.017% |
| Össur hf. | 137.38 Million USD | 104.618% |
| Zecotek Photonics Inc. | -3.44 Million USD | -84.3% |
| QHSLab, Inc. | -91.29 Thousand USD | -6849.054% |
| Wellstar International, Inc. | -1.35 Million USD | -367.668% |
| Össur hf. | 137.38 Million USD | 104.618% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 164.906% |
| Escalon Medical Corp. | -58.46 Thousand USD | -10751.679% |
| Aurora Spine Corporation | -454.37 Thousand USD | -1296.194% |
| BrainsWay Ltd. | -2.31 Million USD | -174.513% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 32.362% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 214.894% |
| Vivos Inc. | -2.79 Million USD | -127.127% |
| MicroPort Scientific Corporation | -347.57 Million USD | 98.175% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -3109.048% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -280.209% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -1574.294% |
| Nanomix Corporation | -8.13 Million USD | 22.062% |
| Theraclion SA | -2.05 Million USD | -209.345% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -797.275% |
| Positron Corporation | -1.45 Million USD | -336.869% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -268.433% |
| Lombard Medical, Inc. | -28.06 Million USD | 77.398% |
| ALR Technologies Inc. | -6.4 Million USD | 0.88% |
| Stratec SE | 39.91 Million USD | 115.894% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 6384.735% |
| Heart Tronics, Inc. | -14.85 Million USD | 57.299% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -5264.497% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 52.218% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 30.682% |
| VMS Rehab Systems, Inc. | -68.55 USD | -9254458.716% |
| Guided Therapeutics, Inc. | -3.12 Million USD | -102.943% |
| Ingen Technologies, Inc. | -8639.00 USD | -73334.425% |
| Odyssey Group International, Inc. | -2.13 Million USD | -196.716% |
| United American Healthcare Corporation | -59 Thousand USD | -10652.542% |
| ECGI Holdings, Inc. | -2.99 Million USD | -112.143% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -908.292% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -1134.181% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -411.877% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -728.234% |
| SS Innovations International, Inc. | -20.37 Million USD | 68.865% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -2747.167% |
| Smith & Nephew plc | 1 Billion USD | 100.633% |
| NIOX Group Plc | 11.07 Million USD | 157.282% |
| Fuse Medical, Inc. | 1.83 Million USD | 445.663% |
| Broncus Holding Corporation | -25.19 Million USD | 74.824% |
| Brain Scientific Inc. | -7.93 Million USD | 20.038% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 32.445% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -34378.261% |